vs
Side-by-side financial comparison of BEYOND MEAT, INC. (BYND) and Laird Superfood, Inc. (LSF). Click either name above to swap in a different company.
BEYOND MEAT, INC. is the larger business by last-quarter revenue ($61.6M vs $13.3M, roughly 4.6× Laird Superfood, Inc.). On growth, Laird Superfood, Inc. posted the faster year-over-year revenue change (15.0% vs -19.7%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs -9.7%).
Beyond Meat, Inc., branded as Beyond, is a producer of plant-based meat alternatives founded in 2009 by Ethan Brown. The company's products were first launched in the United States in 2012.
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
BYND vs LSF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.6M | $13.3M |
| Net Profit | — | $-1.8M |
| Gross Margin | -11.5% | 34.1% |
| Operating Margin | -211.4% | -13.5% |
| Net Margin | — | -13.2% |
| Revenue YoY | -19.7% | 15.0% |
| Net Profit YoY | — | -341.4% |
| EPS (diluted) | $0.68 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.6M | $13.3M | ||
| Q3 25 | $70.2M | $12.9M | ||
| Q2 25 | $75.0M | $12.0M | ||
| Q1 25 | $68.7M | $11.7M | ||
| Q4 24 | $76.7M | $11.6M | ||
| Q3 24 | $81.0M | $11.8M | ||
| Q2 24 | $93.2M | $10.0M | ||
| Q1 24 | $75.6M | $9.9M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-110.7M | $-975.1K | ||
| Q2 25 | $-29.2M | $-362.2K | ||
| Q1 25 | $-52.9M | $-156.2K | ||
| Q4 24 | — | $-398.4K | ||
| Q3 24 | $-26.6M | $-166.1K | ||
| Q2 24 | $-34.5M | $-239.1K | ||
| Q1 24 | $-54.4M | $-1.0M |
| Q4 25 | -11.5% | 34.1% | ||
| Q3 25 | 10.3% | 36.5% | ||
| Q2 25 | 11.5% | 39.9% | ||
| Q1 25 | -1.5% | 41.9% | ||
| Q4 24 | 13.1% | 38.6% | ||
| Q3 24 | 17.7% | 43.0% | ||
| Q2 24 | 14.7% | 41.8% | ||
| Q1 24 | 4.9% | 40.0% |
| Q4 25 | -211.4% | -13.5% | ||
| Q3 25 | -160.0% | -7.7% | ||
| Q2 25 | -46.6% | -3.3% | ||
| Q1 25 | -81.8% | -1.9% | ||
| Q4 24 | -49.3% | -4.1% | ||
| Q3 24 | -38.2% | -2.3% | ||
| Q2 24 | -36.4% | -3.4% | ||
| Q1 24 | -70.7% | -11.0% |
| Q4 25 | — | -13.2% | ||
| Q3 25 | -157.6% | -7.6% | ||
| Q2 25 | -39.0% | -3.0% | ||
| Q1 25 | -77.0% | -1.3% | ||
| Q4 24 | — | -3.4% | ||
| Q3 24 | -32.8% | -1.4% | ||
| Q2 24 | -37.0% | -2.4% | ||
| Q1 24 | -71.9% | -10.3% |
| Q4 25 | $0.68 | — | ||
| Q3 25 | $-1.44 | — | ||
| Q2 25 | $-0.38 | — | ||
| Q1 25 | $-0.69 | — | ||
| Q4 24 | $-0.65 | — | ||
| Q3 24 | $-0.41 | — | ||
| Q2 24 | $-0.53 | — | ||
| Q1 24 | $-0.84 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $203.9M | $5.1M |
| Total DebtLower is stronger | $415.7M | — |
| Stockholders' EquityBook value | $-997.0K | $11.5M |
| Total Assets | $614.7M | $19.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $203.9M | $5.1M | ||
| Q3 25 | $117.3M | $5.1M | ||
| Q2 25 | $103.5M | $3.9M | ||
| Q1 25 | $102.1M | $7.0M | ||
| Q4 24 | $131.9M | $8.3M | ||
| Q3 24 | $121.7M | $7.9M | ||
| Q2 24 | $144.9M | $7.6M | ||
| Q1 24 | $157.9M | $7.1M |
| Q4 25 | $415.7M | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | $-997.0K | $11.5M | ||
| Q3 25 | $-784.1M | $12.8M | ||
| Q2 25 | $-677.0M | $13.4M | ||
| Q1 25 | $-649.5M | $13.3M | ||
| Q4 24 | $-601.2M | $13.2M | ||
| Q3 24 | $-611.9M | $13.1M | ||
| Q2 24 | $-590.0M | $12.6M | ||
| Q1 24 | $-561.4M | $12.7M |
| Q4 25 | $614.7M | $19.2M | ||
| Q3 25 | $599.7M | $18.9M | ||
| Q2 25 | $691.7M | $20.4M | ||
| Q1 25 | $643.8M | $21.5M | ||
| Q4 24 | $678.1M | $19.3M | ||
| Q3 24 | $692.9M | $18.8M | ||
| Q2 24 | $711.2M | $18.0M | ||
| Q1 24 | $735.0M | $17.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-46.8M | $68.4K |
| Free Cash FlowOCF − Capex | $-49.8M | — |
| FCF MarginFCF / Revenue | -80.8% | — |
| Capex IntensityCapex / Revenue | 4.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-157.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-46.8M | $68.4K | ||
| Q3 25 | $-38.8M | $1.2M | ||
| Q2 25 | $-33.2M | $-2.8M | ||
| Q1 25 | $-26.1M | $-1.3M | ||
| Q4 24 | $-29.0M | $339.2K | ||
| Q3 24 | $-22.0M | $305.8K | ||
| Q2 24 | $-16.0M | $642.7K | ||
| Q1 24 | $-31.8M | $-422.3K |
| Q4 25 | $-49.8M | — | ||
| Q3 25 | $-41.7M | — | ||
| Q2 25 | $-35.1M | — | ||
| Q1 25 | $-30.6M | — | ||
| Q4 24 | $-35.4M | — | ||
| Q3 24 | $-24.1M | — | ||
| Q2 24 | $-17.3M | — | ||
| Q1 24 | $-33.0M | — |
| Q4 25 | -80.8% | — | ||
| Q3 25 | -59.4% | — | ||
| Q2 25 | -46.9% | — | ||
| Q1 25 | -44.6% | — | ||
| Q4 24 | -46.2% | — | ||
| Q3 24 | -29.7% | — | ||
| Q2 24 | -18.6% | — | ||
| Q1 24 | -43.7% | — |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BYND
Segment breakdown not available.
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
